Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

FDA rejects ITM's radiopharma drug over manufacturing problems

The FDA rejected ITM Isotope Technologies Munich’s radiopharmaceutical agent for neuroendocrine tumors because of manufacturing issues, delaying a potential challenger to Novartis’ approved drug Lutathera. ITM said the agency cited manufacturing ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 10 August →